Instrument Inactif

Autres langues Cephalon, Inc.

Actions

US1567081096

Papeterie

Cours en clôture Nasdaq
- ^USD	-

04/05/11	CEPHALON : bond des bénéfices au premier trimestre
30/03/11	CEPHALON : Valeant Pharmaceuticals lance une OPA de 5,7 MdUSD sur CEPHALON

Autres langues

05/11/15	AstraZeneca : Teva reach deal with states in Medicaid pricing case
09/12/14	Actavis : Exclusive - Valeant to drop deal-making in near term to cut debt, boost stock
14/10/11	CEPHALON : Teva Completes Acquisition of Cephalon
13/10/11	CEPHALON : Announces Enrollment In the Risk Evaluation and Mitigation Strategy Program for FENTORA and ACTIQ
13/10/11	CEPHALON : Teva and Cephalon Receive European Commission Approval For Acquisition
22/08/11	CEPHALON : Gives Notice of Anticipated Fundamental Change to Holders of Its 2.50% Convertible Senior Subordinated Notes due 2014 and 2.00% Convertible Senior Subordinated Notes due 2015
02/08/11	CEPHALON : Reported Financial Results for the Second Quarter of 2011
21/07/11	CEPHALON : Receives FDA Approval for Risk Evaluation and Mitigation Strategy for FENTORA and ACTIQ
14/07/11	CEPHALON : Shareholders Approve Acquisition by Teva
29/06/11	CEPHALON : to Release Second Quarter 2011 Earnings Results After the Market Close on August 2, 2011
20/05/11	CEPHALON : Granted Temporary Restraining Order in AMRIX® Patent Litigation
20/05/11	CEPHALON : Granted Temporary Restraining Order in AMRIX® Patent Litigation
11/05/11	CEPHALON : Recognizes National Night Shift Worker's Day, Honors America's Shift Workers
04/05/11	CEPHALON : The Law Offices of Vincent Wong Announce an Investigation into Possible Breaches of Fiduciary Duty by the Board of Cephalon, Inc. in Connection with the Sale of the Company to Teva Pharmaceutical Industries Ltd. -- CEPH
04/05/11	CEPHALON : Brower Piven Announces an Investigation of the Acquisition of Cephalon, Inc. by Teva Pharmaceutical Industries Ltd.
03/05/11	CEPHALON : Reported Strong Financial Results for the First Quarter of 2011
03/05/11	CEPHALON : Briscoe Law Firm Investigates Cephalon, Inc. for Shareholders Concerning Acquisition by Teva Pharmaceutical Industries Ltd.
03/05/11	CEPHALON : Goldfarb Branham Law Firm LLP Investigating Shareholder Claims in Cephalon, Inc. Buyout
03/05/11	CEPHALON : The Law Office of Abe Shainberg Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Cephalon, Inc. in Connection with the Sale of the Company to Teva Pharmaceutical Industries Ltd. -- CEPH
02/05/11	CEPHALON : The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Cephalon, Inc. in Connection with the Sale of the Company to Teva Pharmaceutical Industries Ltd. -- CEPH
02/05/11	CEPHALON : to Release First Quarter 2011 Earnings Results After the Market Close on May 3, 2011
02/05/11	CEPHALON : Teva to Acquire Cephalon in $6.8 Billion Transaction
21/04/11	CEPHALON : Valeant Pharmaceuticals Responds to Cephalon Board's Letter
21/04/11	CEPHALON : Files Definitive Consent Revocation Statement, Commences Mailing to Shareholders
21/04/11	CEPHALON : Valeant Pharmaceuticals Announces Letter to Cephalon Stockholders